Untitled
Co-Morbidities and Adverse Drug Reactions in HIV
The Workshop

IMPORTANT UPDATE:
The 2020 International Workshop on Comorbidities & Adverse Drug Reactions in HIV will now be a virtual meeting only.

The Organizing Committee have reviewed the feasibility of the face-to-face 2020 Comorbidities Workshop in view of ongoing COVID-19 pandemic and feel that pursuing a face-to-face meeting is unwise under the current circumstances.

We will hold a series of dynamic and engaging live webcasts, each based around plenary talk, followed by related abstracts and an interactive panel discussion.

Virtual Workshop dates
The virtual Workshop will comprise five 2-hour sessions over 5 consecutive days taking place Monday 30th November – Friday 4th December 2020. Sessions will start ~8am PST, 11am EST, ~5pm CET (exact timings subject to change). For the latest information please regularly visit www.intmedpress.com/comorbidities

2020 plenary speakers
We have an outstanding line-up of keynote speakers - learn more about the faculty

Abstract submission
We are pleased to announce that abstract submission is open for the 2020 virtual Workshop. Abstract submission deadline has been extended to Wednesday 30th September 2020.

Registration
Registration is now open. Please register here.

If you are an Early Stage Investigator or from a low or lower-middle income country defined by World Bank criteria (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519) and wish to submit an abstract, you may qualify for a reduced price registration.

About the International Comorbidities Workshop

Since the first meeting in 1999, The International Workshop on Comorbidities & Adverse Drug Reactions in HIV has continued to distil and disseminate cutting-edge scientific data in the areas of metabolic complications, lipodystrophy and HIV co-morbidities. The Workshop is a key opportunity for scientists, physicians and community activists to exchange information about the latest scientific research and different therapeutic options. Its outputs also serve to stimulate wider discussion of comorbidities in HIV infection and further research. Learn about previous meetings.